← Open Payments lookup

BEN BOSWELL: Open Payments

NPI 1528316122 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,303 in 51 payments from 12 companies in 2025. Trend: 2023 $817 · 2024 $1,065 · 2025 $1,303

Food & beverage: $1,303
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$320
Janssen Pharmaceuticals, Inc12$259
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$254
TRICE MEDICAL, INC.2$193
Otsuka America Pharmaceutical, Inc.4$84
Alkermes, Inc.2$46
E.R. Squibb & Sons, L.L.C.2$43
ABBVIE INC.1$26
Collegium Pharmaceutical, Inc.1$24
Lundbeck LLC1$21

Products named: INGREZZA, INVEGA SUSTENNA, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA, COBENFY, REXULTI, VRAYLAR.

Industry payments across PA — which companies pay providers there.